Loading...
Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
PURPOSE: To compare the immunogenicity and efficacy of insulin glargine biosimilar Ezelin (EZL) versus originator insulin glargine Lantus (LAN) as a reference basal insulin in patients with type 2 diabetes (T2D). PATIENTS AND METHODS: This was a randomized, multicenter, open-label, 24-week study in...
Na minha lista:
| Udgivet i: | Diabetes Metab Syndr Obes |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7811452/ https://ncbi.nlm.nih.gov/pubmed/33469328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S279385 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|